Physician profile
Vanessa Capps
NPI 1336429588
$799.68
in general payments reported to CMS, 2019-2025
9 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.21 · 2022: $52.09 · 2023: $282 · 2024: $37.08 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $141.60 | 2025 | Rezdiffra |
| Otsuka America Pharmaceutical, INC. | $139.81 | 2023 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Nestle Healthcare Nutrition INC. | $124.40 | 2023 | |
| Novo Nordisk INC | $119.85 | 2022-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $105.66 | 2024-2025 | Farxiga, Airsupra |
| Viatris Specialty LLC | $103.95 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $30.84 | 2024-2025 | Camzyos |
| Exact Sciences Corporation | $17.36 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Capps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.